Cargando…

Outcomes for patients with severe chronic neutropenia treated with granulocyte colony-stimulating factor

Severe chronic neutropenia (SCN), defined as blood neutrophils <0.5 × 10(9)/L for >3 months, is an uncommon hematological condition associated with recurrent and severe bacterial infections. After short-term clinical trials showed the benefits of granulocyte colony-stimulating factor (G-CSF) t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dale, David C., Bolyard, Audrey Anna, Shannon, James A., Connelly, James A., Link, Daniel C., Bonilla, Mary Ann, Newburger, Peter E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Hematology 2022
Materias:	Phagocytes, Granulocytes, and Myelopoiesis
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9278291/ https://www.ncbi.nlm.nih.gov/pubmed/35476051 http://dx.doi.org/10.1182/bloodadvances.2021005684

Ejemplares similares

Lymphocyte cytosolic protein 1 (L-plastin) I232F mutation impairs granulocytic proliferation and causes neutropenia
por: Mahat, Upendra, et al.
Publicado: (2022)

Dynamin-2 deficiency causes age- and sex-dependent neutropenia and myelodysplasia in mice
por: Willis, Alexander J., et al.
Publicado: (2022)

Human genetic defects in SRP19 and SRPRA cause severe congenital neutropenia with distinctive proteome changes
por: Linder, Monika I., et al.
Publicado: (2023)

A new murine model of Barth syndrome neutropenia links TAFAZZIN deficiency to increased ER stress-induced apoptosis
por: Sohn, Jihee, et al.
Publicado: (2022)

NADPH oxidase 2 limits amplification of IL-1β–G-CSF axis and an immature neutrophil subset in murine lung inflammation
por: Song, Zhimin, et al.
Publicado: (2022)

Inflammasome activation in neutrophils of patients with severe COVID-19
por: Aymonnier, Karen, et al.
Publicado: (2022)

Neutrophil extracellular traps contribute to immunothrombosis in COVID-19 acute respiratory distress syndrome
por: Middleton, Elizabeth A., et al.
Publicado: (2020)

Lysosomal iron recycling in mouse macrophages is dependent upon both LcytB and Steap3 reductases
por: Meng, Fanjing, et al.
Publicado: (2022)

A neutrophil activation signature predicts critical illness and mortality in COVID-19
por: Meizlish, Matthew L., et al.
Publicado: (2021)

IFNγ regulates NAD(+) metabolism to promote the respiratory burst in human monocytes
por: McCann, Katelyn J., et al.
Publicado: (2022)

Phosphorylation of threonine 154 in p40(phox) is an important physiological signal for activation of the neutrophil NADPH oxidase
por: Chessa, Tamara A. M., et al.
Publicado: (2010)

CD11c regulates neutrophil maturation
por: Hou, Lifei, et al.
Publicado: (2022)

Neutrophil HIF-1α stabilization is augmented by mitochondrial ROS produced via the glycerol 3-phosphate shuttle
por: Willson, Joseph A., et al.
Publicado: (2022)

Secondary bile acids function through the vitamin D receptor in myeloid progenitors to promote myelopoiesis
por: Thompson, Brandon, et al.
Publicado: (2023)

Absolute neutrophil count by Duffy status among healthy Black and African American adults
por: Merz, Lauren E., et al.
Publicado: (2022)

Dasatinib inhibits proinflammatory functions of mature human neutrophils
por: Futosi, Krisztina, et al.
Publicado: (2012)

A NET-thrombosis axis in COVID-19
por: Hidalgo, Andrés
Publicado: (2020)

Resolvin T-series reduce neutrophil extracellular traps
por: Chiang, Nan, et al.
Publicado: (2022)

Impaired formation of neutrophil extracellular traps in patients with MDS
por: Brings, Carolin, et al.
Publicado: (2022)

Clearing NETs with T-series resolvins
por: Filep, János G.
Publicado: (2022)

Transcriptional reprogramming of infiltrating neutrophils drives lung pathology in severe COVID-19 despite low viral load
por: Eddins, Devon J., et al.
Publicado: (2022)

Lack of eosinophil extracellular trap formation due to failure of plasma membrane breakdown in the absence of elastase
por: Sprenkeler, Evelien G. G., et al.
Publicado: (2023)

Tracing the evolutionary history of blood cells to the unicellular ancestor of animals
por: Nagahata, Yosuke, et al.
Publicado: (2022)

Circulating neutrophils maintain physiological blood pressure by suppressing bacteria and IFNγ-dependent iNOS expression in the vasculature of healthy mice
por: Morton, Jonathan, et al.
Publicado: (2008)

Control of coronavirus infection through plasmacytoid dendritic-cell–derived type I interferon
por: Cervantes-Barragan, Luisa, et al.
Publicado: (2007)

Prevention of febrile neutropenia: use of granulocyte colony-stimulating factors
por: Kelly, S, et al.
Publicado: (2009)

The Experience of the Cooperation in Science and Technology European Network for Innovative Diagnosis and Treatment of Chronic Neutropenias (COST EuNet-INNOCHRON) Action and the Sweden Experience in the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Era
por: Spanoudakis, Michail, et al.
Publicado: (2021)

Granulocyte colony-stimulating factor (filgrastim) in chemotherapy-induced febrile neutropenia
por: Advani, S. H., et al.
Publicado: (2010)

Cost-effectiveness of granulocyte colony-stimulating factors (G-CSFs) for the prevention of febrile neutropenia (FN) in patients with cancer
por: Aapro, Matti S., et al.
Publicado: (2023)

Granulocyte Colony-stimulating Factor for Preterms with Sepsis and Neutropenia: A Randomized Controlled Trial
por: Chaudhuri, Jasodhara, et al.
Publicado: (2012)

Clinical practice in febrile neutropenia risk assessment and granulocyte colony-stimulating factor primary prophylaxis of febrile neutropenia in Poland
por: Wojtukiewicz, Marek, et al.
Publicado: (2014)

Evaluating the Prognostic Role of Monocytopenia in Chemotherapy-Induced Febrile Neutropenia Patients Treated with Granulocyte Colony-Stimulating Factor
por: Alshari, Osama, et al.
Publicado: (2021)

Prophylaxis of chemotherapy-induced febrile neutropenia with granulocyte colony-stimulating factors: where are we now?
por: Aapro, Matti, et al.
Publicado: (2010)

Granulocyte-colony-stimulating Factor-resistant Neutropenia and Polyneuropathy Presenting as Severe Complications of Sjögren's Syndrome
por: Tomita, Katsuyuki, et al.
Publicado: (2022)

A case of secondary acute myeloid leukemia on a background of glycogen storage disease with chronic neutropenia treated with granulocyte colony stimulating factor
por: Khalaf, Dina, et al.
Publicado: (2019)

Timing of recombinant human granulocyte colony-stimulating factor administration on neutropenia induced by cyclophosphamide in normal mice.
por: Misaki, M., et al.
Publicado: (1998)

Granulocyte colony-stimulating factors for febrile neutropenia prophylaxis following chemotherapy: systematic review and meta-analysis
por: Cooper, Katy L, et al.
Publicado: (2011)

Incidence of neutropenia and use of granulocyte colony-stimulating factors in multiple myeloma: is current clinical practice adequate?
por: Leleu, Xavier, et al.
Publicado: (2017)

Appropriateness of granulocyte colony-stimulating factor use in patients receiving chemotherapy by febrile neutropenia risk level
por: Baig, Hassam, et al.
Publicado: (2018)

Clozapine rechallenge following neutropenia using granulocyte colony-stimulating factor: A Quebec case series
por: Béchard, Laurent, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_l40tk9722aadngpobac72744ed